Thyroid hormone treatment of acute cardiovascular compromise

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5158978
SERIAL NO

07723716

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for the treatment of patients with acute cardiovascular compromise by administering a therapeutically effective amount of thyroid hormones. Methods of administration are included.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
BRITISH TECHNOLOGY GROUP LIMITEDLONDON87
BTG INTERNATIONAL INC.GULPH MILLS, PA42

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Rubin, Leo Suffern, NY 23 515

Cited Art Landscape

Patent Info (Count) # Cites Year
 
NOVARTIS CORPORATION (1)
* 4666441 Multicompartmentalized transdermal patches 125 1985
 
THERATECH, INC. (1)
* 4863970 Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols 214 1988
 
Key Pharmaceuticals, Inc. (1)
* 4470962 Polymeric diffusion matrix 39 1981
 
RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (1)
* 4818540 Transdermal fertility control system and process 81 1986
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
THE REGENTS OF THE UNIVERSITY OF MICHIGAN (1)
* 5571840 Method for treating central nervous system ischemia 25 1994
 
Other [Check patent profile for assignment information] (7)
* 2003/0198,671 Levothyroxine compositions having unique plasma AUC properties 2 2002
7288257 Diagnosis and treatment of human dormancy syndrome 1 2003
* 2003/0228,628 Diagnosis and treatment of human dormancy syndrome 0 2003
* 2004/0030,365 Medical device to restore functions of a fibrillating heart by cardiac therapies remotely directed by a physician via two-way communication 25 2003
7485298 Diagnosis and treatment of human dormancy-related sequellae 14 2005
7648704 Diagnosis and treatment of human dormancy syndrome 0 2007
* 2008/0089,954 Diagnosis and treatment of human dormancy syndrome 0 2007
 
ST. JUDE MEDICAL AB (2)
* 7248927 Implantable heart stimulator with electrodes for an infection control current 0 2002
* 2004/0098,054 Implantable heart stimulator 4 2003
 
METABASIS THERAPEUTICS, INC. (4)
7829552 Phosphorus-containing thyromimetics 4 2004
7514419 Phosphorus-containing thyromimetics 5 2005
* 2006/0046,980 Novel phosphorus-containing thyromimetics 9 2005
* 2009/0028,925 Novel Phosphinic Acid-Containing Thyromimetics 9 2006
 
ABBOTT GMBH & CO. KG (1)
6706255 Liquid pharmaceutical compositions comprising thyroid hormones 7 2002
 
MYOCARDIOCARE, INC. (5)
7494459 Sensor-equipped and algorithm-controlled direct mechanical ventricular assist device 33 2003
* 2004/0267,086 Sensor-equipped and algorithm-controlled direct mechanical ventricular assist device 60 2003
* 2006/0167,334 Method and apparatus for direct mechanical ventricular actuation with favorable conditioning and minimal heart stress 11 2004
* 2005/0234,289 Therapeutic agent delivery apparatus with direct mechanical ventricular assistance capability 12 2005
* 2006/0142,634 Sensor-equipped and algorithm controlled direct mechanical ventricular assist device 22 2006
 
KNOLL PHARMACEUTICAL COMPANY (1)
* 6458842 Liquid pharmaceutical compositions comprising thyroid hormones 46 1996
 
THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS ("DVA") (1)
* 7504435 Method for stimulating weight loss and/or for lowering triglycerides in patients 0 2005
 
OCERA THERAPEUTICS, INC. (2)
* 9371297 Macrocyclic ghrelin receptor modulators and methods of using the same 0 2008
* 2008/0194,672 MACROCYCLIC GHRELIN RECEPTOR MODULATORS AND METHODS OF USING THE SAME 13 2008
 
NANOPHARMACEUTICALS LLC (8)
9220788 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof 3 2010
9289395 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof 3 2010
9272049 Methods of stimulating fat mobilization using a polymer conjugated polyphenol 3 2011
* 2014/0072,646 THYROID HORMONE ANALOGS AND METHODS OF USE 9 2013
9198887 Thyroid hormone analogs and methods of use 3 2013
9750709 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof 0 2014
9579300 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof 0 2014
9498536 Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders 0 2014
 
CREDIT SUISSE, CAYMAN ISLANDS BRANCH (1)
7101569 Methods of administering levothyroxine pharmaceutical compositions 5 2002
 
NORTH SHORE-LONG ISLAND JEWISH RESEARCH INSTITUTE (2)
6288117 Method for treating congestive heart failure 1 2000
* 2004/0156,893 Method for treating hypothyroidism 4 2003
 
THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (2)
* 6716877 Method to treat chronic heart failure and/or elevated cholesterol levels 3 2003
* 2005/0159,490 Method to treat chronic heart failure and/or elevated cholesterol levels 0 2004
 
RESUSCITEK (1)
* 2005/0059,574 Compositions of stable T3 and methodes of use thereof 2 2001
 
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC (2)
7067148 Stabilized pharmaceutical and thyroid hormone compositions and method of preparation 5 2002
6555581 Levothyroxine compositions and methods 13 2002
 
Bracco S.P.A. (4)
9012438 3,5,3′ -triiodothronine sulfate as thyromimetic agent and pharmaceutical formulations thereof 0 2003
9044441 3,5,3′-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof 0 2013
9468619 3,5,3′-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof 0 2013
9439883 3,5,3′-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof 0 2013
 
AMBRIA DERMATOLOGY AB (2)
* 8642053 Potentiated topical composition 0 2002
* 2004/0248,993 Potentiated topical composition 1 2004
 
Southern Arizona Veterans Affairs Health Care System (1)
6534676 Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same 6 2001
* Cited By Examiner